Briacell Therapeutics
Quarterly Financials
| Values in thousands | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $22 |
Gross Profit | -67 | |||
EBITDA | -6,161 | -7,143 | -5,126 | -5,696 |
EBIT | -6,187 | -7,169 | -5,152 | -5,768 |
Net Income | -6,126 | -6,291 | -5,802 | -1,214 |
Net Change In Cash | 0 | 0 | 0 | 22 |
Free Cash Flow | -7,162 | -5,920 | -6,955 | -4,035 |
Cash | 12,460 | 5,013 | 5,792 | 862 |
Basic Shares | 3,735 | 2 | 1 | 1 |
Annual Financials
| Values in thousands | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -82 | -20 | -19 | -19 |
EBITDA | -4,771 | -22,366 | -34,047 | -6,953 |
EBIT | -4,854 | -22,381 | -34,062 | -6,969 |
Net Income | -4,716 | -20,302 | -11,581 | -2,894 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -16,227 | |||
Free Cash Flow | -24,582 | -23,744 | -12,484 | -7,747 |
Cash | 862 | 21,251 | 41,041 | 57,268 |
Basic Shares | 1 | 1 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-04-30 | -$1.64 |
2025-01-31 | -$2.33 |
2024-10-31 | -$0.22 |
2024-07-31 | -$0.07 |
